Sign Up Today and Learn More About Relievant Medsystems Stock
Invest in or calculate the value of your shares in Relievant Medsystems or other pre-IPO companies through EquityZen's platform.
Relievant Medsystems Stock
Relievant provides patients with low risk therapy that affords the ability to alleviate their back pain.
About Relievant Medsystems Stock
Founded
2004
Headquarters
Redwood City, CA, US
Total Funding
154M
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.
Relievant Medsystems Press Mentions
Stay in the know about the latest news on Relievant Medsystems
Cigna insures Relievant Medsystems back pain treatment
bizjournals • Jun 20, 2023
Relievant Medsystems gets $50M in latest funding round
startribune • Apr 20, 2023
Tech Jobs: Here Are 5 Healthtech Startups With Recent Funding Hiring For Multiple Roles
news • Apr 17, 2023
Relievant Medsystems’ Intracept receives new CPT codes to aid reimbursement efforts
massdevice • Jan 03, 2022
Relievant Medsystems Announces New Vertebrogenic Low Back Pain ICD-10 Diagnosis Code
globenewswire • Oct 02, 2021
Relievant Medsystems Management
Leadership team at Relievant Medsystems
President & CEO
Alex Dinello
Founder & Chief Operating Officer
Rex Peters
Join now and verify your accreditation status to gain access to:
- Relievant Medsystems Current Valuation
- Relievant Medsystems Stock Price
- Relievant Medsystems Management
- Available deals in Relievant Medsystems and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Relievant Medsystems Cap Table and Funding History by Share Class and Liquidity Preferences
- Relievant Medsystems Revenue and Financials
- Relievant Medsystems Highlights
- Relievant Medsystems Business Model
- Relievant Medsystems Risk Factors
- Relievant Medsystems Research Report from SACRA Research
Trading Relievant Medsystems Stock
How to invest in Relievant Medsystems stock?
Accredited investors can buy pre-IPO stock in companies like Relievant Medsystems through EquityZen funds. These investments are made available by existing Relievant Medsystems shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Relievant Medsystems stock?
Shareholders can sell their Relievant Medsystems stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."